Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax donor vaccination in allogeneic stem cell transplant pairs
ACTRN12611000640909Phase 2Not yet recruiting
- Sponsor
- Merck & Co.
- Start
- Jul 2011
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of zoster vaccine, live, sponsored by Merck & Co. Planned start Jul 2011; status: not yet recruiting.
02
Drugs
zoster vaccine, live
Beyond the preview
Go deeper on ACTRN12611000640909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000640909.